Skip to content
Bottneuro AG logo — Precision medicine for brain health

Bottneuro AG

Precision medicine for brain health

Founded 2021 Switzerland Switzerland 12 employees Convertible Note Total: $4.15M Health Care, Health and Wellness

General Information

Company Name Bottneuro AG
Founded Year 2021
Location Switzerland Switzerland
Founders / Decision Makers
Team member
Employees 12
Industries Health Care, Health and Wellness
Funding Stage Convertible Note
Social

BounceWatch is an independent company data service, not affiliated with Bottneuro AG. To contact Bottneuro AG, visit bottneuro.ch.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Bottneuro AG compare?

A PDF of Bottneuro AG and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Bottneuro AG soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Bottneuro AG

Bottneuro AG is a Switzerland-based health care startup founded in 2021. The company is focused on developing non-invasive custom-made tCS/EEG devices for the diagnosis and treatment of neurological diseases. Emphasizing precision medicine for brain health, Bottneuro's innovative approach involves capturing brainwave patterns for early intervention and conducting multifocal electrical stimulation sessions of specific brain regions through personalized, 3D-printed, wearable headsets. The company's solution integrates both software and hardware components, including a tablet and a neckpiece housing the electronics and in-house developed brush electrodes, eliminating the need for shaving. Notably, electrode placement is calculated based on MRI scans of the patient's head to stimulate only the disease-affected regions, with the 3D-printed cap ensuring repeated and precise electrode positioning for each stimulation session. In December 2022, Bottneuro received a significant Fr.4.00M investment through a Convertible Note from Zühlke Ventures AG, Hemex, and DART Ventures. This funding is expected to further support the company's development of innovative solutions in the field of precision medicine for brain health.

Business keywords: neurological diseases, diagnosis, treatment, brainwave patterns, multifocal electrical stimulation, wearable headsets, 3D-printed technology, MRI scans, electrode placement, personalized treatment, non-invasive, brain health, neuroscience

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Convertible Note Fr.4.00M 3
Zühlke Ventures AG, Hemex +1
15 Dec 2022
Grant Undisclosed 1
IMD Startup Competition
12 Dec 2022
Grant Fr.150.00K 1
Venture Kick
17 Dec 2021

Bottneuro AG Alternatives & Competitors

View All Alternatives
Bottneuro AG vs
Nexstim
Nexstim Finland

We enable personalized and effective therapies and diagnostics for challenging brain diseases and di...

Post-IPO Debt
52 employees
Biotechnology, Health Care
Bottneuro AG vs
Modalis TMS
Modalis TMS Australia

WA's trusted name in using Transcranial Magnetic Stimulation (TMS) to treat depression & more | Pert...

15 employees
Health Care, Health and Wellness
Bottneuro AG vs
Neuronetics, Inc.
Neuronetics, Inc. United States

Non-drug, safe, effective treatment for depression and other mental health conditions.

Post-IPO Debt
220 employees
Biotechnology, Health Care

FAQ About Bottneuro AG

Precision medicine for brain health
Bottneuro AG was founded in 2021.
Bottneuro AG is headquartered in Switzerland.
Bottneuro AG operates in Health Care and Health and Wellness. Its work centres on neurological diseases, diagnosis, treatment and brainwave patterns.
Bottneuro AG has approximately 12 employees.
Bottneuro AG has completed 3 funding rounds, raising a total of $4.15M. The latest funding stage is Convertible Note.
Top alternatives and competitors to Bottneuro AG include Nexstim, Modalis TMS, Neuronetics, Inc., MYndspan, Clarity. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Bottneuro AG and Nexstim are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Bottneuro AG, https://bouncewatch.com/company/bottneuro-ag, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout